Objectives. To characterize hand synovial manifestations assessed by power Doppler ultrasonography (PDUS) in a cohort of unselected patients fulfilling the 2013 ACR/EULAR classification criteria for SSc and to evaluate the associations of these synovial manifestations with the main general clinical and biological features of SSc.
Introduction
SSc is a rare autoimmune disorder characterized by vascular hyper-reactivity and fibrosis of skin and internal organs such as lungs. Beyond vascular and fibrotic manifestations, SSc is also considered an inflammatory disorder [1] . Inflammatory manifestations of SSc include synovial involvement, which especially concerns synovial of joints and tendons of the hand [2] . Previous studies have reported non-specific synovial manifestations of the disease characterized by inflammatory synovitis and tenosynovitis (TS) in almost half of SSc patients [24] . Alongside these inflammatory synovial manifestations of the disease, a sclerosing pattern of TS has also been described as a specific fibrotic characteristic of the disease [5] . This specific sclerosing TS is clinically characterized by palpable tendon friction rubs [6] . Power Doppler ultrasonography (PDUS) has proven to be an efficient non-invasive tool to assess these synovial manifestations of the disease [7] . PDUS evaluation has especially a higher sensitivity than clinical examination to detect sclerosing TS and inflammatory synovial involvement in SSc. Nonetheless, these previous PDUS studies were based on small sample sizes, limiting the conclusions concerning associations of PDUS features with general clinical or immunological characteristics of the disease. Moreover, the diagnosis of SSc in these studies was based on LeRoy's or 1980 ACR classification criteria for SSc [8, 9] . The EULAR/ACR classification criteria for SSc proposed by van den Hoogen et al. [10] , have a higher specificity and sensitivity in comparison with LeRoy's classification or the 1980 ACR criteria [10, 11] . The 2013 ACR/EULAR classification criteria are therefore considered as the gold standard for the inclusion of SSc patients in clinical studies. However, this new classification does not include any articular parameters, neither unspecific inflammatory features nor more specific manifestations such as sclerosing TS. The prevalence of synovial involvement assessed by PDUS in unselected patients fulfilling 2013 ACR classification criteria for SSc is still to be determined.
Recent insights in the pathogenesis of SSc have highlighted the importance of inflammatory features, especially in the early stages of the disease [12] . New promising therapeutic approaches have emerged from these observations [1315] . Anti-inflammatory drugs targeting key pro-inflammatory and pro-fibrotic pathways such as IL-6/JAK/STAT3 signals have shown promising results in recent clinical trials [14] . These therapeutic approaches, such as tocilizumab (anti-IL-6 receptor) or tofacitinib (JAK1/3 inhibitor), have proven to be efficient in other rheumatic diseases such as RA [16] . As some of these drugs are evaluated in the treatment of fibrotic manifestations of SSc, that is, skin fibrosis and interstitial lung disease (ILD), they may also have a place in the management of synovial manifestations of the disease [14] . Consequently, a more refined and updated description of synovial involvement assessed by PDUS seems necessary, especially as PDUS may help to select the patients that would benefit the most from these new targeted antiinflammatory drugs.
The objective of this study was to characterize hand synovial and tenosynovial manifestations assessed by PDUS in a cohort of unselected patients fulfilling the 2013 EULAR/ACR classification criteria for SSc and to evaluate the associations of these synovial manifestations of the disease with the main general clinical and biological features of SSc.
Methods

Patients
Between November 2014 and November 2016, 103 unselected consecutive SSc patients referred to the rheumatology unit were consecutively included in this observational study. The diagnosis of SSc was based on the ACR/EULAR 2013 classification criteria [10] . Patients were also sub-classified in the dcSSc or lc/sine scleroderma (lcSSc) subsets according to LeRoy's classification [8] . Visceral and serological evaluations were performed in accordance with standard recommended practice. The mode of onset of the disease (first non-RP symptom) was recorded. Arthralgia was defined as a pain involving wrists or hands, as first non-RP symptom and at inclusion as a cross-sectional parameter. Inflammatory arthralgia was defined as a pain involving wrist or hands with inflammatory characteristics, that is, pain improving with movement and/or resulting in nocturnal awakenings and/or morning joint stiffness.
Patients suffering from overlap syndromes with other CTDs responsible for tenosynovial manifestations (RA, primary SS and SLE) were not included. The investigator performing PDUS evaluations was blinded for the results of clinical, serological and X-ray evaluations. Likewise, investigators performing clinical and X-ray evaluations were blinded for the results of PDUS hand assessment.
PDUS evaluation
PDUS evaluation was conducted in accordance with the OMERACT guidelines. A MyLab Class C (Esaote, 16152 Genova, Italy, 2013) US device was used with a 618 MHz linear array transducer. B-mode and PD machine settings were standardized as follows: B-mode frequency of 18 MHz, B-mode gain of 5060%, Doppler frequency of 10 MHz, Doppler gain of 5060%, low wall filters and pulse repetition frequency of 750 Hz, depending on the depth of the anatomic area. All US examinations were performed by a single rheumatologist (G.C.) with a 10-year experience in musculoskeletal US.
US examination was performed on joints of both hands [MCPs (15) , PIPs (15) and DIPs (15); dorsal longitudinal view] and both wrists (radio-ulnar, medio-carpal and radio-carpal; systematic dorsal longitudinal and dorsal transverse views). In both hands, extensor tendons and tendon sheaths of the fingers were evaluated using a transverse dorsal view of the wrist (compartments 2, 3, 4, 5 and 6) with an additional longitudinal view in case of pathologic findings. Flexor tendons and proper tendon sheaths of all fingers were evaluated using a palmar transverse view, and flexor digitocarpal sheath inside the carpal tunnel was also evaluated using a palmar transverse view. An additional longitudinal view was systematically performed in case of pathologic findings.
Synovial inflammation was defined as a synovial or tenosynovial hypertrophy on B-mode with PD signal (Fig. 1AC) according to the OMERACT definitions [17, 18] . Synovitis was defined as a hypoechoic synovial hypertrophy that was non-displaceable and poorly compressible, with or without PDUS signal (grade 2 or 3 according to OMERACT criteria were considered Doppler-positive synovitis). According to standard procedure, careful attention was paid to limit pressure on the tendon sheaths, in order to assure sensitivity of US evaluation for detecting TS. Sclerosing TS (Figs 1D, E and 2) was defined as an iso-or hyperechoic hypertrophy of the tendon sheath with concentric alternating iso-and/or hyperechoic layers on transverse view. This tenosynovial feature is classically described as the artichoke heart or onion bulb sclerosing pattern (Fig. 2) [3, 7] .
The ethics committee of Rennes Hospital approved this observational study (approvals 14.53 and 15.09). The study complied with the recommendations of the Declaration of Helsinki. Informed consent was obtained from all patients prior to investigations.
Statistics
Qualitative data associations were analysed conducting Chi-square test or Fisher's exact test and expressed with odds ratio (OR) and 95% CIs. Quantitative data were analysed conducting the unpaired two-tailed Student's t-test or MannWhitney U test depending on Gaussian distribution. We performed all tests with a significance level of P < 0.05. Statistical analysis was performed using SPSS 20.0 software. 
Results
Clinical characteristics and main PDUS features
Clinical characteristics of the 103 SSc patients are summarized in supplementary Table S1 , available at Rheumatology online. The majority of patients were female. Mean (S.D.) disease duration since first non-RP symptom was 7.6 years (8.2). One-third of the patients had dcSSc. X-ray evaluations were missing for six patients. Ultrasonographic inflammatory TS was rare (only four patients). All patients with ultrasonographic inflammatory TS (n = 4) had positive Doppler synovitis. Sclerosing TS was not associated with positive Doppler synovitis (P = 0.095; OR = 2.77, 95% CI: 0.88, 8.70). Characteristics and location of synovial manifestations are summarized in Table 1 and supplementary Table S2 , available at Rheumatology online.
Association of ultrasonographic synovial involvement with general clinical characteristics
Thirty-three patients (32%) had ultrasonographic synovial involvement (all types of ultrasonographic synovial manifestations). Synovial involvement was significantly associated with arthralgia as first non-RP symptom (Table 2) . Synovial involvement was more frequent in male. ACAs were more frequent in patients without US synovial involvement. On the contrary, anti-RNA polymerase III antibodies, CRP levels >5 mg/l, dcSSc, ILD, pericarditis and inflammatory arthralgia were significantly associated with the presence of synovial involvement on US evaluation. There was no association of ultrasonographic synovial manifestations with other auto-antibodies (data not shown). There was no association of calcinosis or acroosteolysis on X-rays with ultrasonographic synovial involvement (P = 0.098; OR = 2.06, 95% CI: 0.87, 4.87 and This characteristic aspect is usually compared to the concentric layers seen in an onion bulb, as illustrated on these pictures. TS: tenosynovitis. P = 0.156; OR = 1.88, 95% CI: 0.78, 4.54, respectively). Digital ulcers (DUs) as mode of onset/first non-RP symptom were not associated with ultrasonographic synovial involvement ( Table 2) . History of DU only tended to be associated with ultrasonographic synovial involvement (P = 0.070; OR = 2.18, 95% CI: 0.93, 5.06).
General clinical features of SSc and specific fibrotic or inflammatory PDUS features
Sclerosing TS were associated with the main general fibrotic features of the disease (Table 3) : diffuse cutaneous involvement as first non-RP symptom, dcSSc at inclusion and ILD. Male were more frequently concerned by sclerosing TS. Sclerosing TS was associated with anti-RNA polymerase III antibodies. Calcinosis or acro-osteolysis on X-rays and DU history were not associated with sclerosing TS (data not shown).
Ultrasonographic inflammatory synovial manifestations in SSc patients (Doppler-positive synovitis or TS) were associated with CRP levels >5 mg/l, pericarditis, arthralgia and, more significantly, with inflammatory arthralgia (Table 4) . Calcinosis or acro-osteolysis on X-rays and DU history were not associated with ultrasonographic inflammatory synovial manifestations (data not shown).
Discussion
To our knowledge, this work is the first and largest study evaluating hand ultrasonographic synovial involvement in a cohort of unselected patients fulfilling 2013 ACR classification criteria for SSc. Our work confirms the high prevalence of synovial involvement in SSc, which concerns one-third of the patients in this study. Wrist and MCP were the most frequently concerned joints. SSc-specific sclerosing TS was present in 19 patients (18.4%) and was especially associated with the positivity of anti-RNA polymerase III antibodies and diffuse cutaneous involvement, as first non-RP symptom or as a cross-sectional parameter.
Concerning the prevalence of synovial involvement in SSc, our results are consistent with previous studies based on older classification criteria [24] . The association of ultrasonographic sclerosing TS with diffuse cutaneous involvement and anti-RNA polymerase III antibodies has never been described before. This might be explained by the limited sample size of previous studies evaluating this US parameter and by the absence of data concerning RNA polymerase III antibodies in these studies [24] . Tendon friction rubs, the physical manifestation associated with sclerosing TS in the hand, has already been shown to be associated with diffuse cutaneous involvement or ILD [5] . Our study confirms the association of these general fibrotic manifestations of the disease with sclerosing TS on US evaluation, which has proven to have a higher sensitivity than clinical evaluation for detecting fibrotic tenosynovial impairment of the hand in SSc. Nonetheless, our results need to be validated in other independent cohorts, with larger sample size. If sclerosing TS may be associated with tendon friction rubs in the upper-arms of SSc patients, this sclerosing pattern of tendon sheaths cannot explain all manifestations of friction rubs, especially outside the hand, around tendons devoid of synovial sheath such as quadricipital or Achilles tendons. Sclerosing TS may therefore constitute one of the fibrotic manifestations characterizing infiltrates of the connective tissue surrounding tendons, but not the only one. The specific association of clinical tendon friction rubs with sclerosis TS was not evaluated in our work and this issue should be addressed in the future, with imaging techniques such as body MRI, which offers not only evaluation of hand involvement but also whole-body assessment. Unlike US evaluation, this technique is not easily available in daily practice, but has already offered promising results to decipher the pathologic anatomical bases of tendon friction rubs, beyond hands and upper arms [19] .
Another manifestation in the hand of SSc patients is the unusual high prevalence of A1 pulley thickening [20] . Contrary to sclerosing TS, A1 pulley thickening is not specific to SSc. The US presentation of sclerosing TS may share some characteristics with A1 pulley thickening; nonetheless the location of sclerosing TS is not at the level of the A1 pulley, demonstrating that sclerosing TS involves the tendon sheath itself and not the pulley (Fig. 1E and supplementary Fig. S1 , available at Rheumatology online). We did not specifically evaluate A1 pulley thickening in our study but this feature may constitute another fibrotic manifestation involving the connective tissue surrounding tendons in SSc. The association of A1 pulley thickening with hand disability and general clinical features of SSc may help to better characterize this manifestation in the future. Elhai et al. [3] and Cuomo et al. [4] have both demonstrated that sclerosing TS is a highly specific synovial manifestation of SSc. Inflammatory TS and synovitis are in contrast less specific. We found an association of inflammatory synovial involvement with higher CRP levels. This result is concordant with previous studies [3] . Interestingly, this inflammatory synovial involvement was associated with other inflammatory features of the disease such as pericardial effusion. In our study, patients suffering from overlap syndromes with other connective tissue diseases responsible for tenosynovial manifestations were not included (RA, primary SS and SLE). Nonetheless, even though patients had hand X-rays to detect microcrystalline arthritis, gouts or chondrocalcinosis may have participated in the inflammatory synovial manifestations in our patients. A dedicated study evaluating the prevalence of microcrystalline arthritis in patients fulfilling 2013 ACR classification criteria for SSc is therefore warranted.
As our study was especially designed to assess synovial involvement in SSc, we have not specifically studied calcinosis using US evaluation. This is one of the limitations of our work. Calcinosis was evaluated using X-rays, which is considered as the gold standard method to assess this musculoskeletal manifestation of SSc [21, 22] . Nevertheless, the precise prevalence of intra-synovial calcinosis is still to be determined and for some patients, intra-articular calcinosis may contribute to the pathogenesis of some inflammatory musculoskeletal manifestations of SSc [7] . Another limitation of our study is the absence of direct comparison of some characteristics assessed through physical examination (like tendon friction rubs, joint swelling) and US characteristics. Evaluating the diagnostic performances of PDUS was not the objective of our study. The high sensitivity of US evaluation for detecting synovial involvement in SSc patients has already been demonstrated before and this was therefore not an original teaching point [24, 6, 7] . Our objective was indeed to highlight the associations of ultrasonographic synovial and tenosynovial involvement with the main general features of SSc, within a clinical and imaging phenotyping approach. In addressing this issue, we aim to place hand ultrasonographic musculoskeletal findings in the current global picture of the disease as defined by the 2013 classification criteria. Likewise, we did not perform multivariate analyses in this study as this was an exploratory study and considering that our objective was purely descriptive. We did not aim to explore independent parameters explaining synovial involvement using an analytic approach, we only aimed to underscore the prevalence of the main specific synovial US features in SSc and their association with the general clinical characteristics of the disease. Moreover, proper logistic regression models would have implied a larger sample size to achieve relevant and reliable results [23] .
From a pathophysiological view point, one interesting result of our work is the association of sclerosing TS with arthralgia as first non-RP symptom. The pathogenesis of sclerosing TS is still to be determined in SSc. This association of sclerosing TS and arthralgia as first non-RP symptom supports the hypothesis that sclerosing TS might be a natural evolution of inflammatory TS. This result also supports the hypothesis that inflammation precedes fibrosis in SSc [1, 14] . As tendon friction rubs/sclerosing TS have proven to be associated with a more severe functional hand impairment in SSc [24] , there is a need for efficient therapeutic strategies to manage this manifestation of the disease. Considering that sclerosing TS might be a natural evolution of inflammatory TS, an early antiinflammatory treatment approach for these inflammatory musculoskeletal manifestations of the disease might be an adapted therapeutic option to limit the occurrence of sclerosing TS. However, although patients were consecutively included, the cross-sectional design of the analysis, without any longitudinal follow-up, precludes any conclusions regarding causality and only prospective longitudinal studies will provide precise information on the natural history of sclerosing TS. These pathophysiological and therapeutic considerations must be taken very carefully and are still purely hypothetic. The long-term followup results of clinical trials evaluating anti-inflammatory targeted strategies in SSc, like the faSScinate trial [14, 25, 26] , a phase II randomized controlled trial evaluating the safety and efficacy of subcutaneous tocilizumab (anti-IL-6 receptor) in SSc, may also help to evaluate the impact of an early anti-inflammatory treatment on musculoskeletal manifestations of SSc and on the occurrence of sclerosing TS. A EUSTAR study has recently demonstrated that joint synovitis and tendon friction rubs were independent predictive factors for disease progression in patients with early SSc [5] . Beyond pathophysiological considerations, US longitudinal evaluations of SSc patients will also provide some insight into the prognostic value of synovial and TS impairment detect by PDUS of the hand in SSc.
There was no association of DU history, calcinosis or acro-osteolysis with ultrasonographic synovial involvement. Digital vasculopathy and micro-angiopathy are supposed to play a key role in the pathogenesis of calcinosis and acro-osteolysis in SSc. Indeed, cross-sectional studies have highlighted the association of acroosteolysis with Cutolo's late pattern in nailfold capillaroscopy [27] . The history of DUs or digital ischaemia is also associated with acro-osteolysis [22] . Moreover, a recent study has demonstrated that macrovascular features of SSc such as ulnar artery occlusion assessed by PDUS were also associated with acro-osteolysis, and to a lesser extent with calcinosis [28] . The absence of a significant association of any synovial manifestations with DU history, calcinosis or acro-osteolysis could suggest that synovial involvement in SSc might not be the direct result of the vasculopathy characterizing the disease. Once again, the cross-sectional design of the study limits conclusions regarding causality. We also cannot exclude a lack of power due to the limited sample size, which could have masked existing associations. Capillaroscopic evaluation was not performed simultaneously to US evaluation for all patients in our work, we were therefore not able to draw reliable conclusions regarding the association of microvascular capillaroscopic findings with ultrasonographic tenosynovial or synovial involvement, and did not include capillaroscopic considerations in this study. Further studies are necessary to clarify this issue in the future.
Two recent editorials published in Rheumatology have underscored the relevance of PDUS evaluation to assess musculoskeletal or vascular involvement in SSc [29, 30] . These editorials have also called for further studies to evaluate the relevance of PDUS in the evaluation of skin thickness or lung involvement and to determine the role of PDUS for vascular assessment in comparison with nailfold capillaroscopic evaluation [31, 32] . PDUS is a widely available tool that offers the unique opportunity of a combined dynamic evaluation of macro-vascular involvement, as demonstrated by our group and others [28, 32, 33] , and hand synovial impairment as illustrated by the present study. US evaluation should not replace physical examination of the hand but may help to describe more precisely the pathologic mechanisms involving the hand in SSc. As a new initiative for re-shaping SSc clustering is emerging, PDUS may have a part to play in the description of more refined phenotypes, with a more accurate and precise description of musculoskeletal involvement and with the addition of new macro-vascular considerations [34, 35] . In December 2015, Ligon and Wigley [36] called for a revision of the black-or-white system of diffuse vs limited scleroderma, arguing that a better description of clinical SSc phenotypes over time and their interaction with serological considerations would offer a wider spectrum of clusters, proposing a new heterogeneous 'Technicolor' vision of SSc. The use of PDUS in multicentre longitudinal studies on SSc may help to frame this 'Technicolor' vision of this rare and still incompletely understood connective tissue disorder. A more sophisticated and precise evaluation of the wide range of clinical manifestations of SSc may be essential to better understand the mechanisms underlying each feature of the disease and therefore to propose the best-adapted therapeutic approach. PDUS evaluation of the hand might therefore have a part to play in the global management of SSc and in the assessment of specific manifestations of the disease, as the question of a treat-to-target approach is arising for SSc.
